Victory Capital Management Inc Logic Bio Therapeutics, Inc. Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$4.25 - $8.46 $24,730 - $49,228	-5,819 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$4.06 - $11.0 $11,445 - $31,009	2,819 Added 93.97%	5,819 $29,000
Q4 2019 Feb 06, 2020	SELL	$7.01 - $11.01 $20,209 - $31,741	-2,883 Reduced 49.01%	3,000 $22,000
Q4 2019 Feb 04, 2020	SELL	$7.01 - $11.01 $2,222 - $3,490	-317 Reduced 5.11%	5,883 $58,000
Q3 2019 Nov 12, 2019	BUY	$6.97 - $13.46 $22,304 - $43,072	3,200 Added 106.67%	6,200 $67,000
Q4 2018 Feb 05, 2019	BUY	$7.88 - $17.98 $23,640 - $53,940	3,000 New	3,000 $31,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.